Company OpGen Inc Nasdaq

Equities

US68373L1098

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Biotechnology & Medical Research

Inactive Instrument

OpGen, Inc. (OpGen) is a precision medicine company using molecular diagnostics and informatics to combat infectious disease. The Company is engaged in developing molecular information solutions to combat infectious disease in global healthcare settings, helping to guide clinicians with information about life threatening infections, managing patient outcomes, and the spread of infections caused by multidrug-resistant microorganisms. Its deoxyribonucleic acid (DNA) tests and bioinformatics address the threat of anti-biotic resistance by helping physicians and healthcare providers manage patient care decisions and protect the hospital biome through customized screening and surveillance solutions. It is working to deliver its molecular information solution to a global network of customers and partners. It is also working to provide precise diagnostic information powered by pathogen surveillance data. The Company's high-resolution DNA tests are marketed under the Acuitas trade name.

USD in Million	2021	Weight	2022	Weight	Delta
Molecular Diagnostics and Informatics 72.6 %	3	61.7 %	2	72.6 %	-28.71%
Collaboration 20.7 %	1	19.4 %	1	20.7 %	-35.32%
Laboratory Services 6.6 %	1	18.9 %	0	6.6 %	-78.77%

USD in Million	2021	Weight	2022	Weight	Delta
International 80.0 %	3	72.0 %	2	80.0 %	-32.74%
United States 20.0 %	1	28.0 %	1	20.0 %	-56.75%

Managers	Title	Age	Since
Albert Weber DFI	Director of Finance/CFO	60	21-12-31
Johannes Bacher COO	Chief Operating Officer	55	20-03-31
Oliver Schacht PRN	Corporate Officer/Principal	53	20-03-31

Members of the board	Title	Age	Since
Oliver Schacht PRN	Corporate Officer/Principal	53	20-03-31

Name	Equities	%	Valuation
David Natan 0.9986 %	100,000	0.9986 %	69 500 $
Avraham Ben-Tzvi 0.9986 %	100,000	0.9986 %	69 500 $
David Lazar 0.9986 %	100,000	0.9986 %	69 500 $
Matthew McMurdo 0.9986 %	100,000	0.9986 %	69 500 $
Renaissance Technologies LLC 0.6591 %	66,000	0.6591 %	45 870 $
Vanguard Group, Inc. (Subfiler) 0.5320 %	53,275	0.5320 %	37 026 $
Virtu Financial LLC 0.4033 %	40,384	0.4033 %	28 067 $
Geode Capital Management LLC 0.3671 %	36,755	0.3671 %	25 545 $
Citadel Securities GP LLC 0.3633 %	36,377	0.3633 %	25 282 $
Oliver Schacht 0.1969 %	19,719	0.1969 %	13 705 $

OpGen, Inc.

9717 Key West Avenue Suite 100

20850, Rockville

+240 813 1260

http://www.opgen.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+1.51%	42.59B
MODERNA, INC.	+8.57%	40.65B
LONZA GROUP AG	+49.22%	40.57B
CELLTRION, INC.	-12.36%	26.77B
ICON PUBLIC LIMITED COMPANY	+8.92%	24.81B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.17B
MEDPACE HOLDINGS, INC.	+29.17%	12.05B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.7B
UNITED THERAPEUTICS CORPORATION	+6.35%	11.1B

Other Biotechnology & Medical Research